Tower Research Capital LLC (Trc) Bluebird Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,109 shares of BLUE stock, worth $5,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,109
Previous 38,728
60.99%
Holding current value
$5,590
Previous $37,000
81.08%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding BLUE
# of Institutions
151Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$5.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$3.88 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.73 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.73 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$1.42 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $28.5M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...